Insider buying last 90 days
No open-market insider purchases were filed for ALAB in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Astera Labs fell this week after its Q3 report, even as results beat expectations: earnings rose with Scorpio X-Series strength driving 153.7% revenue growth and $584.90 million in revenue against adjusted earnings of $1.32 per share, ahead of the $1.19 estimate. Management guided Q4 revenue to $730-$750 million and pointed to expansion into optical connectivity, memory and rack-scale AI systems. Despite the beat-and-raise, shares slid, and Roth Capital trimmed its price target to $350 from $450 while keeping a Buy rating; another firm upgraded the stock to Hold following the post-IPO selloff, and some analysts cut forecasts even as they acknowledged the growth trajectory.
ALAB closes at $223.27, down 4.4% on the day, sitting below both its 50-day average of $304.94 and its 200-day average of $255.97. The GekkoIndex reads 71.4, placing the stock in the Buying zone. Price sits 33.9% below the Gekko Fair Value of $337.84, a gap flagged as more than 5% below fair value.
The next earnings date is 9 February 2027, 96 days out, so no report falls within the next 20 trading days. Over the last 30 days there have been 3 unusual options signals, with call premium of $29,463,739 against put premium of $3,825,815. Analyst coverage includes 9 Buy and 5 Hold ratings among 14 firms, with a consensus target of $387.57. The prior earnings reaction was a decline of 2.8% despite the beat, worth noting given the stock's typical 20-day move of 19.8%.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Astera Labs scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Averages disagree
Close $223.27 sits between the 50-day ($304.94) and 200-day ($255.97) averages, or the averages disagree.
See the chart71.4, Buying
Reading 71.4 is in the Buying zone.
See the GekkoIndex33.9% below
Price is 33.9% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 30 days: 3 unusual options signals.
See smart moneyReports in 96 days
Next report Feb 9, 2027, 96 days away — outside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Astera Labs closed at $223.27 on Nov 4, 2026, +16.6% over the past year, inside a 52-week range of $97.89 to $499.48.
Use the left and right arrow keys to read daily values.
Put ALAB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Astera Labs designs and supplies semiconductor-based connectivity products used in cloud computing and artificial intelligence systems. Its main line of business centers on what it calls the Intelligent Connectivity Platform, a set of data, network, and memory connectivity offerings tied together under a single software-defined design. This platform is the company's most recognized product line.
The company builds its products to work as a unified system rather than standalone parts, allowing customers running large-scale cloud and AI infrastructure to deploy and manage high-performance connectivity across their operations. Its customers are organizations that operate this kind of demanding, large-scale computing environment.
Astera Labs was founded in 2017 and is headquartered in Santa Clara, California. Its shares are listed on the NASDAQ under the ticker ALAB.
Astera Labs’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 71.4, in the Buying zone, up 9.9 points over five sessions.
Up 9.9 points over five sessions, from the Accumulation zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying (current zone) | 20 | −1.2% | −7.0% | ||
| Accumulation | 246 | +0.6% | +2.6% | ||
| Neutral | 321 | +2.9% | +11.8% | ||
| Distribution | 65 | +2.4% | +17.5% | ||
| Selling | 0 | Not available | |||
Average ALAB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +3.0% over 20 days. Past behaviour doesn’t guarantee future results.
Buying zone: Smart money likely accumulating heavily. About the five zones →
Astera Labs trades 33.9% below Gekko Fair Value of $337.84, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Astera Labs shares are worth, recalculated every trading day.
$337.84
Gekko Fair Value, Nov 4, 2026
33.9% Undervalued
At the end of Aug 2026 the price was 20.3% below the estimate.
No open-market insider purchases were filed for Astera Labs, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ALAB in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ALAB were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Astera Labs has been buying back its own shares.
From company filings.
3signals, 89% of the flagged premium in calls.
Latest: Bullish flow on Oct 31, $15.41M in unusual premium.
3of the funds Gekko tracks hold ALAB.
Astera Labs reports on Feb 9, 2027, after the close (96 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 9, 2027
Expected after the close, 96 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 3, 2026 | $1.32 est $1.19 | $584.9M est $550.8M | −2.8% |
| Aug 4, 2026 | $0.29 est $0.42 | $392.4M est $360.9M | −0.8% |
| May 5, 2026 | $0.61 est $0.54 | $308.4M est $292.2M | +6.3% |
| Feb 10, 2026 | $0.58 est $0.51 | $270.6M est $249.5M | −23.4% |
| Nov 4, 2025 | $0.49 est $0.39 | $230.6M est $206.5M | −5.0% |
| Aug 5, 2025 | $0.44 est $0.32 | $191.9M est $172.5M | +26.4% |
| May 6, 2025 | $0.33 est $0.28 | $159.4M est $153.1M | −1.5% |
| Feb 10, 2025 | $0.37 est $0.26 | $141.1M est $151.6M | −9.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Astera Labs is $387.57, +73.6% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Stifel Nicolaus | $370 | +65.7% |
| Nov 4 | Bank of America Securities | — | — |
| Nov 4 | Barclays | $325 | +45.6% |
| Nov 4 | TD Cowen | $225 | +0.8% |
| Nov 4 | RBC Capital | $400 | +79.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Astera Labs’s market cap is $38.73B, with a P/E ratio of 127.6 and revenue of $1.20B over the last twelve months.
Coverage of Astera Labs this week reads neutral: 5 positive, 8 neutral and 0 negative headlines.
Astera Labs’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| NVDANVIDIA | Accumulation | 25.3% below |
| AVGOBroadcom | Accumulation | 7.7% below |
| MUMicron Technology | Accumulation | 40.7% below |
| AMDAdvanced Micro Devices | Accumulation | 9.1% below |
| INTCIntel | Buying | 33.9% below |
| TXNTexas Instruments | Neutral | 15.3% above |
A peer links to its own page where one exists.
Astera Labs’s market cap is $38.73B at the Nov 4, 2026 close of $223.27, with 173.5M shares outstanding. The shares trade on a P/E ratio of 127.6.
The consensus analyst 12-month price target for Astera Labs is $387.57, +73.6% from the last close. Of the 14 firms that rated the stock in the last 90 days, 9 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Astera Labs is undervalued: the Nov 4, 2026 close of $223.27 is 33.9% below Gekko Fair Value of $337.84. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Astera Labs is expected to report on Feb 9, 2027, after the market closes (96 days away). Analysts expect earnings of $1.42 per share on revenue of $656.3M. Astera Labs beat the earnings estimate in 7 of its last 8 reports, moving 9.4% on average across the report.
Astera Labs’s 52-week high is $499.48 and its 52-week low is $97.89; it closed at $223.27 on Nov 4, 2026, +16.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
Gekko flagged 3 unusual options signals in Astera Labs over the last 30 days, with $29.46M of flagged premium in calls and $3.83M in puts. The latest, bullish flow, was on Oct 31, 2026 with $15.41M in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,460 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.